Data show ATryn effectively prevents serious blood clots

BOSTON, Mass., July 16, 2009 -- Data presented at the annual meeting of the International Society on Thrombosis and Haemostasis (ISTH) in Boston show that ATryn® (Antithrombin [Recombinant]) safely prevents peri-operative and peri-partum acute deep vein thrombosis (DVT) or other venous thromboembolic events in patients with hereditary antithrombin deficiency (HD AT).

Read the whole article on Science Blog

More from Science Blog